Abstract
The microorganisms causing leprosy and leishmaniasis are both intracellular pathogens in the human host, infecting principally cells of macrophage lineage; there is abundant evidence that effective protective immunity to both pathogens depends upon T-lymphocyte mediated reactivity. The vaccination model which has been developed and evaluated in our studies is oriented toward correcting this antigen-specific deficiency in affected patients through the presentation of heat-inactivated specific and non-specific antigens of the infective microorganism together with viable BCG. Both immunotherapeutic and immuno-prophylactic applications of this model are discussed in this paper.
Cite
CITATION STYLE
Convit, J., Ulrich, M., Aranzazu, N., Castellanos, P. L., Pinardi, M. E., & Reyes, O. (1986). The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis. Leprosy Review, 57(SUPPL. 2), 263–273. https://doi.org/10.5935/0305-7518.19860080
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.